Ozempic / GLP-1 Lawsuits Lawsuit in Pennsylvania

Preparing your case review…
Written By
People's Justice Legal Research Team

Statute of Limitations

Pennsylvania has a 2-year SOL for products liability (42 Pa. C.S.A. § 5524). Discovery rule applies.

2 years from diagnosis or discovery

Pennsylvania Data

Exposure in Pennsylvania

Source: MDL 3094

Source: Court records

Source: MDL scheduling order

Medical Resources

Clinics & Specialists in Pennsylvania

Temple University Hospital — GI Motility Center

The Team

Your Legal Team

KR

Katherine Reynolds

Senior Partner

Philadelphia, PA

20+ Years Experience
Pharmaceutical litigationGLP-1 receptor agonist claimsMDL leadershipProducts liability

Katherine Reynolds has spent 20 years representing patients harmed by pharmaceutical products. Based in Philadelphia — the home of GLP-1 MDL 3094 — she has direct access to the MDL court and discovery proceedings. Katherine serves on the Plaintiffs' Steering Committee and has been instrumental in shaping the litigation strategy for gastroparesis and NAION claims.

Education

  • J.D., University of Pennsylvania Law School (2004)
  • B.S., Biochemistry, Georgetown University (2001)
Back to Ozempic / GLP-1 Lawsuits Lawsuit Overview